60 Degrees Pharmaceuticals, Inc. (SXTP)
Automate Your Wheel Strategy on SXTP
With Tiblio's Option Bot, you can configure your own wheel strategy including SXTP - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol SXTP
- Rev/Share 0.5106
- Book/Share 4.5435
- PB 0.9302
- Debt/Equity 0.0
- CurrentRatio 3.1347
- ROIC -2.4655
- MktCap 4300842.0
- FreeCF/Share -3.6456
- PFCF -0.9192
- PE -0.3655
- Debt/Assets 0.0
- DivYield 0
- ROE -2.3931
- Rating C-
- Score 1
- Recommendation Strong Sell
- P/E Score 1
- DCF Score 1
- P/B Score 4
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
Babesiosis Incidence in U.S. 10x Higher Than CDC Estimates, According to Insurance Claims Study Commissioned by 60 Degrees Pharmaceuticals
Published: June 03, 2025 by: GlobeNewsWire
Sentiment: Neutral
Insurance claims show U.S. babesiosis incidence may be 10x CDC estimates; 60 Degrees links chronic fatigue and plans 2026 NDA for tafenoquine treatment.
Read More
Babesiosis Disease Burden in United States is Substantially Higher Than Official Estimates, According to Preliminary Results of 60 Degrees Pharma Survey
Published: April 22, 2025 by: GlobeNewsWire
Sentiment: Neutral
60 Degrees Pharma survey suggests babesiosis affects up to 3M Americans—vastly more than CDC data—and may underlie millions of chronic fatigue cases.
Read More
60 Degrees Pharmaceuticals and Fathom Holdings Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Published: February 21, 2025 by: Accesswire
Sentiment: Neutral
ORLANDO, FL / ACCESS Newswire / February 21, 2025 / RedChip Companies will air interviews with 60 Degrees Pharmaceuticals, Inc. (Nasdaq:SXTP) and Fathom Holdings Inc. (Nasdaq:FTHM) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV this Saturday, February 22, at 7 p.m. Eastern Time (ET).
Read More
Sixty Degrees Pharmaceuticals to Ensure Continuity of Tafenoquine Supply in U.S. by Importing Limited Quantity of KODATEF®
Published: February 11, 2025 by: GlobeNewsWire
Sentiment: Neutral
WASHINGTON, Feb. 11, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (“60 Degrees” or the “Company”), pharmaceutical company today announced that the United States Food and Drug Administration (FDA) does not object to the Company's plan to import KODATEF® (tafenoquine) from Australia as a one-time, preemptive measure against any near-term disruption in the U.S. supply of ARAKODA® (tafenoquine). ARAKODA is an antimalarial indicated for the prophylaxis of malaria in patients aged 18 years and older in the United States (U.S.) It is sold under the brand name KODATEF in Australia, where it is indicated for the prevention …
Read More
About 60 Degrees Pharmaceuticals, Inc. (SXTP)
- IPO Date 2023-07-12
- Website https://60degreespharma.com
- Industry Biotechnology
- CEO Dr. Geoffrey Stuart Dow Ph.D.
- Employees 3